Cardioprotection and Matrix Metalloproteinase-9 Regulation of Salvianolic Acids on Myocardial Infarction in Rats

Abstract

Acute myocardial infarction (AMI) remains the leading cause of mortality in the world. Early intervention using salvianolic acids (SA) can substantially improve clinical outcomes. However, in spite of the great achievements that have been made in elucidating the protective effects of SA on AMI, the effects of SA on the contractile performance of the left ventricle (LV) and the underlying mechanism are still not so clear. In the present study, AMI was introduced by ligation of the left anterior descending coronary artery near the main pulmonary artery. Administration of SA significantly decreased infarct size, improved LV function and appearance of the myocardium and decreased myocardial malondialdehyde levels compared with the AMI group. Furthermore, treatment with SA significantly downregulated the mRNA expression level and activity of matrix metalloproteinase-9 (MMP-9), but did not regulate the tissue inhibitor of metalloproteinase-1 (TIMP-1) expression level at the infarct area. Lisinopril (an angiotensin converting enzyme inhibitor), which holds potential effects on cardioprotection, was chosen as the positive control in this study. Lisinopril elevated LV function and appearance of the myocardium, decreased malondialdehyde levels without an influence on infarct size, and regulated the MMP-9 enzyme level but not the MMP-9 mRNA and TIMP-1 protein levels. These findings suggest that early SA treatment is effective to improve LV function; and SA may exert preventative effects against myocardial remodeling after infarction.

Salvia miltiorrhiza - Labiatae - salvianolic acids - acute myocardial infarction - matrix metalloproteinase‐9 - cardioprotection

References

• 1 Judd J T, Wexler B C. Prolyl hydroxylase and collagen metabolism after experimental myocardial infarction.  Am J Physiol. 1975;  228 212-216
• 2 Jugdutt B I. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?.  Circulation. 2003;  108 1395-1403
• 3 Janicki J S, Brower G L, Gardner J D, Chancey A L, Stewart Jr J A. The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.  Heart Fail Rev. 2004;  9 33-42
• 4 Ahmed S H, Clark L L, Pennington W R, Webb C S, Bonnema D D, Leonardi A H, McClure C D, Spinale F G, Zile M R. Matrix metalloproteinases/tissue inhibitors of metalloproteinases relationship between changes in proteolytic dceterminants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.  Circulation. 2006;  113 2089-2096
• 5 Brower G L, Gardner J D, Forman M F, Murray D B, Voloshenyuk T, Levick S P, Janicki J S. The relationship between myocardial extracellular matrix remodeling and ventricular function.  Eur J Cardiothorac Surg. 2006;  30 604-610
• 6 Gallagher G, Menzie S, Huang Y, Jackson C, Hunyor S N. Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep.  Basic Res Cardiol. 2007;  102 63-72
• 7 Rohde L E, Aikawa M, Cheng G C, Sukhova G, Solomon S D, Libby P, Pfeffer J, Pfeffer M A, Lee R T. Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction.  J Am Coll Cardiol. 1999;  33 835-842
• 8 Chang P N, Mao J C, Huang S H, Ning L, Wang Z J, On T, Duan W, Zhu Y Z. Analysis of cardioprotective effects using purified Salvia miltiorrhiza extract on isolated rat hearts.  J Pharmacol Sci. 2006;  101 245-249
• 9 Shi C S, Huang H C, Wu H L, Kuo C H, Chang B I, Shiao M S, Shi G Y. Salvianolic acid B modulates hemostasis properties of human umbilical vein endothelial cells.  Thromb Res. 2007;  119 769-775
• 10 Zhang H S, Wang S Q. Salvianolic acid B from Salvia miltiorrhiza inhibits tumor necrosis factor-α(TNF-α)-induced MMP‐2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species.  J Mol Cell Cardiol. 2006;  41 138-148
• 11 Kang E S, Lee G T, Kim B S, Kim C H, Seo G H, Han S J, Hur K Y, Ahn C W, Ha H, Jung M, Ahn Y S, Cha B S, Lee H C. Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats.  Eur J Pharmacol. 2008;  579 418-425
• 12 Lima C F, Valentao P C, Andrade P B, Seabra R M, Fernandes-Ferreira M, Pereira-Wilson C. Water and methanolic extracts of Salvia officinalis protect HepG2 cells from t-BHP induced oxidative damage.  Chem Biol Interact. 2007;  167 107-115
• 13 Jiang B, Zhang L, Li M, Wu W, Yang M, Wang J, Guo D A. Salvianolic acids prevent aculte doxorubicin cardiotoxiciy in mice through suppression of oxidative stress.  Food Chem Toxicol. 2008;  46 1510-1515
• 14 Yao Y, Wu W Y, Liu A H, Deng S S, Bi K S, Liu X, Guo D A. Interaction of salvianolic acids and notoginsengnosides in inhibition of ADP-induced platelet aggregation.  Am J Chin Med. 2008;  36 313-328
• 15 Ling S, Dai A, Guo Z, Komesaroff P A. A preparation of herbal medicine Salvia miltiorrhiza reduces expression of intercellular adhesion molecule-1 and development of atherosclerosis in apolipoprotein E-deficient mice.  J Cardiovasc Pharmacol. 2008;  51 38-44
• 16 Liu A H, Guo H, Ye M, Lin Y H, Sun J H, Xu M, Guo D A. Detection, characterization and identification of phenolic acids in Danshen using high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry.  J Chromatogr A. 2007;  1161 170-182
• 17 Yamamoto D, Takai S, Jin D, Inagaki S, Tanaka K, Miyazaki M. Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP‐9.  J Mol Cell Cardiol. 2007;  43 670-676
• 18 Yamamoto D, Takai S, Miyazaki M. Prediction of interaction mode between a typical ACE inhibitor and MMP‐9 active site.  Biochem Biophys Res Commun. 2007;  354 981-984
• 19 Jiang B, Hattori N, Liu B, Kitagawa K, Inagaki C. Expression of swelling-and/or pH-regulated chloride channels (ClC‐2, 3, 4 and 5) in human leukemic and normal immune cells.  Life Sci. 2002;  70 1383-1394
• 20 Martin M U, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.  Biochim Biophys Acta. 2002;  1592 265-280
• 21 Spinale F G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.  Physiol Rev. 2007;  87 1285-1342
• 22 Mukherjee R, Mingoia J T, Bruce J A, Austin J S, Stroud R E, Escobar G P, McClister Jr D M, Allen C M, Alfonso-Jaume M A, Fini M E, Lovett D H, Spinale F G. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.  Am J Physiol Heart Circ Physiol. 2006;  291 H2216-H2228
• 23 Karim M A, Ferguson A G, Wakim B T, Samarel A M. In vivo collagen turnover during development of thyroxine-induced left ventricular hypertrophy.  Am J Physiol. 1991;  260 C316-C326
• 24 Cleutjens J P, Verluyten M J, Smiths J F, Daemen M J. Collagen remodeling after myocardial infarction in the rat heart.  Am J Pathol. 1995;  147 325-338
• 25 Tao Z Y, Cavasin M A, Yang F, Liu Y H, Yang X P. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice.  Life Sci. 2004;  74 1561-1572
• 26 Long C S. The role of interleukin-1 in the failing heart.  Heart Fail Rev. 2001;  6 81-94
• 27 Wilson E M, Moainie S L, Baskin J M, Lowry A S, Deschamps A, Mukherjee R, Guy T S, John-Sutton St MG, Gorman 3rd J H. Region- and type-specific induction of matrix metalloproteinases in post-myocardial infarction remodeling.  Circulation. 2003;  107 2857-2863